TocilizumabV1, Main, Merge, indexHead, AutAff.i

Xu K < Xu L < Xu M

Author's uniq id: Xu L
Total number of names:
Total number of records with affiliations: 88

L Xu

NONE (BIBLIO)

000027
000033
000089
000113
000131
000132
000177
000246
000263
000268
000305
000363
000435
000543
000553
000580
000592
000745
000795
000845
000874
000923
000A36
000C16
000C31
000C35
000C72
000D03
000D44
000E64
001033
001249
002454
002777
003500

L-P Xu

NONE (BIBLIO)

000305

L-p Xu

NONE (BIBLIO)

000305

L. J. Xu

NONE (BIBLIO)

001255

L. Xu

République populaire de Chine Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Nanjing	003328
NONE (BIBLIO)	000080 000096 000099 000119 000197 000243 000259 000322 000342 000348 000374 000389 000431 000519 000524 000577 000665 000778 000787 000799 000916 000A48 000A55 000C04 000F62 001255 001311 001A39 002331

L.-J. Xu

NONE (BIBLIO)

000799

L.-X. Xu

NONE (BIBLIO)

002331

L.H. Xu

NONE (BIBLIO)

000787

L.Y. Xu

NONE (BIBLIO)

000E00

LA Xu

NONE (BIBLIO)

000E78

LC Xu

NONE (BIBLIO)

000D88
001035

LG Xu

NONE (BIBLIO)

002005

LH Xu

NONE (BIBLIO)

000947

LL Xu

NONE (BIBLIO)

002807

LP Xu

NONE (BIBLIO)

000305
000780

LQ Xu

NONE (BIBLIO)

000027

LY Xu

NONE (BIBLIO)

000971

Lanping Xu

Peking University People's Hospital, Peking University Institute of Haematology, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Collaborative Innovation Centre of Haematology, Peking University, Beijing, China.
République populaire de Chine
Peking University People's Hospital, Peking University Institute of Haematology, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Collaborative Innovation Centre of Haematology, Peking University, Beijing
Pékin

001840

Li-An Xu

États-Unis New Jersey Bristol‐Myers Squibb, Hopewell	003763
États-Unis Global Biometric Sciences, Bristol-Myers Squibb, Princeton, New Jersey New Jersey	003608

Linxiaoqing Xu

Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
Japon
Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba
Chiba

002044

Liyun Xu

NONE

003D06

Lu Xu

a School of Bioscience and Bioengineering , South China University of Technology , Guangzhou , China.
République populaire de Chine
a School of Bioscience and Bioengineering , South China University of Technology , Guangzhou
Guangzhou

004557

<g><k>Xu L</k>
<l><g><k>L Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000027</i>
<i>000033</i>
<i>000089</i>
<i>000113</i>
<i>000131</i>
<i>000132</i>
<i>000177</i>
<i>000246</i>
<i>000263</i>
<i>000268</i>
<i>000305</i>
<i>000363</i>
<i>000435</i>
<i>000543</i>
<i>000553</i>
<i>000580</i>
<i>000592</i>
<i>000745</i>
<i>000795</i>
<i>000845</i>
<i>000874</i>
<i>000923</i>
<i>000A36</i>
<i>000C16</i>
<i>000C31</i>
<i>000C35</i>
<i>000C72</i>
<i>000D03</i>
<i>000D44</i>
<i>000E64</i>
<i>001033</i>
<i>001249</i>
<i>002454</i>
<i>002777</i>
<i>003500</i>
</l>
<n>35</n>
<t>35</t>
</g>
</l>
<n>1</n>
<t>35</t>
</g>
<g><k>L-P Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000305</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>L-p Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000305</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>L. J. Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>001255</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>L. Xu</k>
<l><g><k><affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing</wicri:regionArea>
<wicri:noRegion>Nanjing</wicri:noRegion>
</affiliation>
</k>
<l><i>003328</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000080</i>
<i>000096</i>
<i>000099</i>
<i>000119</i>
<i>000197</i>
<i>000243</i>
<i>000259</i>
<i>000322</i>
<i>000342</i>
<i>000348</i>
<i>000374</i>
<i>000389</i>
<i>000431</i>
<i>000519</i>
<i>000524</i>
<i>000577</i>
<i>000665</i>
<i>000778</i>
<i>000787</i>
<i>000799</i>
<i>000916</i>
<i>000A48</i>
<i>000A55</i>
<i>000C04</i>
<i>000F62</i>
<i>001255</i>
<i>001311</i>
<i>001A39</i>
<i>002331</i>
</l>
<n>29</n>
<t>29</t>
</g>
</l>
<n>2</n>
<t>30</t>
</g>
<g><k>L.-J. Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000799</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>L.-X. Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>002331</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>L.H. Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000787</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>L.Y. Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000E00</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>LA Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000E78</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>LC Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000D88</i>
<i>001035</i>
</l>
<n>2</n>
<t>2</t>
</g>
</l>
<n>1</n>
<t>2</t>
</g>
<g><k>LG Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>002005</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>LH Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000947</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>LL Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>002807</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>LP Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000305</i>
<i>000780</i>
</l>
<n>2</n>
<t>2</t>
</g>
</l>
<n>1</n>
<t>2</t>
</g>
<g><k>LQ Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000027</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>LY Xu</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000971</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>Lanping Xu</k>
<l><g><k><affiliation wicri:level="3"><nlm:affiliation>Peking University People's Hospital, Peking University Institute of Haematology, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Collaborative Innovation Centre of Haematology, Peking University, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Peking University People's Hospital, Peking University Institute of Haematology, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Collaborative Innovation Centre of Haematology, Peking University, Beijing</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</k>
<l><i>001840</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>Li-An Xu</k>
<l><g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Bristol‐Myers Squibb, Hopewell</wicri:cityArea>
</affiliation>
</k>
<l><i>003763</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Global Biometric Sciences, Bristol-Myers Squibb, Princeton, New Jersey</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</k>
<l><i>003608</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>2</n>
<t>2</t>
</g>
<g><k>Linxiaoqing Xu</k>
<l><g><k><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba</wicri:regionArea>
<wicri:noRegion>Chiba</wicri:noRegion>
</affiliation>
</k>
<l><i>002044</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>Liyun Xu</k>
<l><g><k><affiliation>NONE</affiliation>
</k>
<l><i>003D06</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>Lu Xu</k>
<l><g><k><affiliation wicri:level="1"><nlm:affiliation>a School of Bioscience and Bioengineering , South China University of Technology , Guangzhou , China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>a School of Bioscience and Bioengineering , South China University of Technology , Guangzhou </wicri:regionArea>
<wicri:noRegion>Guangzhou </wicri:noRegion>
</affiliation>
</k>
<l><i>004557</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>22</n>
<t>88</t>
</g>

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021

	Serveur d'exploration Tocilizumab
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Tocilizumab